Andrew L Sussman1, Deborah Helitzer2, Anzia Bennett3, Angélica Solares4, Marianna Lanoue5, Christina M Getrich6. 1. Department of Family and Community Medicine, University of New Mexico, Albuquerque, New Mexico asussman@salud.unm.edu. 2. Department of Family and Community Medicine, University of New Mexico, Albuquerque, New Mexico. 3. Agri-Cultura Network, Albuquerque, New Mexico. 4. Barelas Community Coalition, Albuquerque, New Mexico. 5. Thomas Jefferson University, Philadelphia, Pennsylvania. 6. Department of Anthropology, University of Maryland, College Park, Maryland.
Abstract
PURPOSE: Data confirm that high rates of human papillomavirus (HPV) vaccination have not been achieved despite strong clinician endorsement of the vaccine. We conducted a study of primary care clinicians to assess the broad range of health care delivery, health policy, and attitudinal factors influencing vaccination uptake and opportunities for informed decision making. METHODS: We implemented a mixed methods study in RIOS Net, a primary care practice-based research network in New Mexico. We first conducted qualitative, in-depth interviews with primary care clinicians, health policy makers, and immunization experts, and followed up with a confirmatory survey distributed to RIOS Net clinician members. RESULTS: Health service delivery challenges emerged as the greatest barrier to HPV vaccination, specifically the lack of capacity to track and distribute reminders to eligible patients. Clinicians also reported variations in counseling approaches attributable to both age and emphasis on the cancer prevention benefits of the vaccine. There was no evidence of sociocultural influences on vaccine decision making, nor did concerns about perceived overprotection emerge. CONCLUSIONS: Our findings, based on a long-term program of research, suggest that both patients' attributes and health system delivery are most influential in HPV vaccination coverage challenges. Interventions targeting innovative communication techniques, as well as health system changes that build on efforts toward coordinated care and utilization of other venues to promote vaccination, will be necessary to address these challenges.
PURPOSE: Data confirm that high rates of human papillomavirus (HPV) vaccination have not been achieved despite strong clinician endorsement of the vaccine. We conducted a study of primary care clinicians to assess the broad range of health care delivery, health policy, and attitudinal factors influencing vaccination uptake and opportunities for informed decision making. METHODS: We implemented a mixed methods study in RIOS Net, a primary care practice-based research network in New Mexico. We first conducted qualitative, in-depth interviews with primary care clinicians, health policy makers, and immunization experts, and followed up with a confirmatory survey distributed to RIOS Net clinician members. RESULTS: Health service delivery challenges emerged as the greatest barrier to HPV vaccination, specifically the lack of capacity to track and distribute reminders to eligible patients. Clinicians also reported variations in counseling approaches attributable to both age and emphasis on the cancer prevention benefits of the vaccine. There was no evidence of sociocultural influences on vaccine decision making, nor did concerns about perceived overprotection emerge. CONCLUSIONS: Our findings, based on a long-term program of research, suggest that both patients' attributes and health system delivery are most influential in HPV vaccination coverage challenges. Interventions targeting innovative communication techniques, as well as health system changes that build on efforts toward coordinated care and utilization of other venues to promote vaccination, will be necessary to address these challenges.
Authors: Amy B Middleman; Susan L Rosenthal; Vaughn I Rickert; Lawrence Neinstein; Daniel B Fishbein; Lawrence D'Angelo Journal: J Adolesc Health Date: 2006-03 Impact factor: 5.012
Authors: Gwendolyn P Quinn; Devin Murphy; Teri L Malo; Juliette Christie; Susan T Vadaparampil Journal: J Pediatr Adolesc Gynecol Date: 2012-04-18 Impact factor: 1.814
Authors: Andrew L Sussman; Deborah Helitzer; Margaret Sanders; Brisa Urquieta; Melina Salvador; Khadidiatou Ndiaye Journal: Ann Fam Med Date: 2007 Jul-Aug Impact factor: 5.166
Authors: Randall Starling; Jessica A Nodulman; Alberta S Kong; Cosette M Wheeler; David B Buller; W Gill Woodall Journal: J Consum Health Internet Date: 2014-01-01
Authors: Laurie D Elam-Evans; David Yankey; Jenny Jeyarajah; James A Singleton; Robinette C Curtis; Jessica MacNeil; Susan Hariri Journal: MMWR Morb Mortal Wkly Rep Date: 2014-07-25 Impact factor: 17.586
Authors: Yvonne N Flores; Jorge Salmerón; Beth A Glenn; Cathy M Lang; L Cindy Chang; Roshan Bastani Journal: Int J Public Health Date: 2018-12-01 Impact factor: 3.380
Authors: Cynthia A Bonville; Joseph B Domachowske; Donald A Cibula; Manika Suryadevara Journal: Hum Vaccin Immunother Date: 2017-10-13 Impact factor: 3.452
Authors: Rose Gunn; Laura K Ferrara; Caitlin Dickinson; Isabel Stock; Jennifer Griffith-Weprin; Amy Wiser; Brigit Hatch; L J Fagnan; Patricia A Carney; Melinda M Davis Journal: Am J Prev Med Date: 2020-06-27 Impact factor: 5.043